STAT3 and chronic myelogenous leukemia, BCR-ABL1 positive: Increased STAT3 activation was also observed in our murine CML model, where 86% of IM-persistent LSCs having pSTAT3-Y705 as opposed to 12% of untreated LSCs (Fig. 1D).